CYTK
Cytokinetics Inc
62.90$
+1.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 32.8% | 70.2% | 464.5% | 648.8% | 403.7% | – | 420.2% | 347.3% | 201.0% | 248.2% | 278.2% | 336.5% | 334.1% | 351.8% | 568.3% | 606.5% | 58.1% | 434.7% | 482.0% | 1,281.9% | 890.9% | 78.2% | 4,001.3% | 64.2% | 2,494.4% | 3,833.3% | 1,721.7% | 9,595.6% | 21,833.9% | 5,082.3% | 9,768.9% | 31,966.7% | 18,274.7% | 553.1% | 6,323.1% | 3.4% | 138.4% | 16.1% | 12.4% | 8.6% | 15.0% | |
| 67.2% | 29.8% | -364.5% | -548.8% | -303.7% | – | -320.2% | -247.3% | -101.0% | -148.2% | -178.2% | -236.5% | -234.1% | -251.8% | -468.3% | -506.5% | 41.9% | -334.7% | -382.0% | -1,181.9% | -790.9% | 21.8% | -3,901.3% | 35.8% | -2,394.4% | -3,733.3% | -1,621.7% | -9,495.6% | -21,733.9% | -4,982.3% | -9,668.9% | -31,866.7% | -18,174.7% | -453.1% | -6,223.1% | 96.6% | -38.4% | 83.9% | 87.6% | 91.4% | 85.0% | |
| 32.8% | 56.7% | 464.5% | 648.8% | 403.7% | – | 420.2% | 347.3% | 201.0% | 248.2% | 278.2% | 336.5% | 334.1% | 351.8% | 568.3% | 606.5% | 58.1% | 434.7% | 482.0% | 1,281.9% | 890.9% | 78.2% | 4,001.3% | 64.2% | 2,494.4% | 3,833.3% | 1,721.7% | 9,595.6% | 21,833.9% | 5,082.3% | 9,768.9% | 31,966.7% | 18,274.7% | 553.1% | 6,323.1% | 168.6% | 5,125.7% | 571.9% | 493.5% | 306.5% | 555.4% | |
| 12.2% | 20.1% | 195.4% | 276.4% | 156.3% | – | 175.9% | 129.5% | 67.3% | 80.6% | 111.5% | 137.8% | 161.1% | 203.1% | 325.5% | 394.1% | 29.5% | 206.9% | 238.2% | 745.6% | 481.9% | 60.8% | 2,880.7% | 48.0% | 1,917.4% | 2,757.7% | 1,076.6% | 4,581.5% | 10,611.4% | 2,638.4% | 5,449.1% | 20,411.2% | 12,235.9% | 368.3% | 3,633.2% | 98.4% | 3,587.7% | 516.6% | 542.0% | 327.1% | 522.1% | |
| 12.2% | 6.6% | 195.4% | 276.4% | 156.3% | – | 175.9% | 129.5% | 67.3% | 80.6% | 111.5% | 137.8% | 161.1% | 203.1% | 325.5% | 394.1% | 29.5% | 206.9% | 238.2% | 745.6% | 481.9% | 60.8% | 2,880.7% | 48.0% | 1,917.4% | 2,757.7% | 1,076.6% | 4,581.5% | 10,611.4% | 2,638.4% | 5,449.1% | 20,411.2% | 12,235.9% | 368.3% | 3,633.2% | 263.6% | 8,575.0% | 1,088.5% | 1,036.3% | 642.6% | 1,078.0% | |
| 55.0% | 23.2% | -559.9% | -825.2% | -459.9% | – | -496.0% | -376.7% | -168.3% | -228.8% | -289.7% | -374.3% | -395.2% | -454.8% | -793.8% | -900.6% | 12.4% | -541.6% | -620.2% | -1,927.4% | -1,272.8% | -39.0% | -6,782.0% | -12.2% | -4,311.8% | -6,491.1% | -2,698.3% | -14,077.2% | -32,345.2% | -7,620.7% | -15,118.0% | -52,277.9% | -30,410.6% | -821.4% | -9,856.3% | -167.0% | -8,613.4% | -1,004.6% | -948.7% | -551.1% | -993.0% | |
| 1.0% | 2.2% | 63.0% | 127.3% | 63.6% | – | 94.8% | 84.2% | 51.0% | 63.0% | 70.8% | 90.2% | 110.1% | 158.6% | 250.5% | 272.9% | 22.6% | 143.8% | 103.6% | 244.2% | 130.9% | 15.9% | 811.0% | 11.0% | 626.9% | 831.3% | 287.0% | 1,541.8% | 3,702.6% | 1,020.6% | 2,074.4% | 9,758.6% | 4,816.0% | 133.5% | 1,453.2% | 36.3% | 1,359.6% | 170.9% | 172.2% | 109.1% | 175.9% | |
| 54.0% | 21.6% | -622.9% | -952.5% | -523.6% | – | -574.8% | -442.8% | -206.9% | -282.3% | -347.0% | -450.0% | -488.4% | -587.9% | -1,030.2% | -1,135.0% | -7.6% | -653.5% | -719.4% | -2,165.1% | -1,399.4% | -55.0% | -7,791.4% | -22.3% | -5,658.4% | -7,019.9% | -2,846.1% | -14,837.0% | -34,238.6% | -8,187.6% | -16,244.7% | -57,557.4% | -34,674.9% | -886.3% | -10,220.1% | -201.2% | -15,815.0% | -1,030.9% | -1,064.5% | -622.8% | -1,259.9% | |
| -0.3% | -0.5% | -10.1% | -14.4% | -7.3% | – | 3.2% | 8.2% | 9.9% | 13.0% | 13.5% | 10.7% | 11.3% | 25.5% | 18.9% | 26.9% | 1.3% | 24.9% | 4.4% | 6.6% | -4.2% | 15.3% | 1,009.4% | 10.1% | 1,346.7% | -302.5% | -40.1% | 767.8% | 1,819.7% | 110.5% | 274.0% | – | – | – | – | – | – | – | – | – | – | |
| 54.0% | 21.6% | -622.9% | -952.5% | -523.6% | – | -574.8% | -442.8% | -206.9% | -282.3% | -347.0% | -450.0% | -488.4% | -587.9% | -1,030.2% | -1,135.0% | -7.6% | -653.5% | -719.4% | -2,165.1% | -1,399.4% | -55.0% | -7,791.4% | -22.3% | -5,658.4% | -7,019.9% | -2,846.1% | -14,837.0% | -34,238.6% | -8,187.6% | -16,244.7% | -57,557.4% | -34,674.9% | -886.3% | -10,220.1% | -201.2% | -15,815.0% | -1,030.9% | -1,064.5% | -622.8% | -1,259.9% | |
| 57.8% | 10.3% | -539.2% | -790.8% | -440.0% | – | -467.3% | -348.7% | -153.4% | -219.2% | -272.8% | -355.8% | -372.8% | -421.8% | -783.1% | -850.5% | 13.7% | -502.7% | -607.6% | -1,901.8% | -1,260.0% | -34.9% | -6,843.8% | -9.0% | -4,948.5% | -6,048.5% | -2,498.7% | -12,973.4% | -30,045.5% | -6,788.1% | -13,891.1% | -46,832.5% | -29,338.2% | -738.7% | -8,621.3% | -161.5% | -14,317.0% | -1,014.8% | -874.8% | -611.4% | -1,158.1% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.